Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses

[1]  Eun Jeong Kim,et al.  NCCN Guidelines Insights: Antiemesis, Version 2.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  M. Aapro,et al.  Identifying cancer patients at high risk for chemotherapy-induced nausea and vomiting (CINV): the development of a prediction tool , 2016 .

[3]  M. Kris,et al.  Antiemetics: American Society of Clinical Oncology Focused Guideline Update. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. Bruera,et al.  2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  M. Kris,et al.  Antiemetics: American Society of Clinical Oncology Focused Guideline Update. , 2016, Journal of oncology practice.

[6]  M. Aapro,et al.  Advances in the Management of Chemotherapy-Induced Nausea and Vomiting: New Data From Recent and Ongoing Trials. , 2015, Clinical advances in hematology & oncology : H&O.

[7]  G. Lyman,et al.  Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens. , 2015, American health & drug benefits.

[8]  M. Aapro,et al.  Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  H. Friedman,et al.  Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice , 2014, Supportive Care in Cancer.

[10]  Stephen Szabo,et al.  Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study. , 2014, Journal of oncology practice.

[11]  A. Jatoi,et al.  Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers , 2014, Supportive Care in Cancer.

[12]  A. Molassiotis,et al.  Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting , 2013, Supportive Care in Cancer.

[13]  G. Dranitsaris,et al.  Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting. , 2012, The journal of supportive oncology.

[14]  M. Aapro,et al.  Antiemetic Prophylaxis of Chemotherapy-Induced Nausea and Vomiting , 2013 .

[15]  A. Molassiotis,et al.  The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  J. Verweij,et al.  Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. , 1997, British Journal of Cancer.

[17]  D. Carney,et al.  Chemotherapy induced nausea and vomiting. , 1994, Irish medical journal.